ELVN FY 2025 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ELVNEnliven Therapeutics, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$263,000

Operating Income

-$120M

Net Income

-$104M

EPS (Diluted)

$-1.83

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$70M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$476M

Total Liabilities

$17M

Stockholders' Equity

$460M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$263,000	$0	—
Operating Income	-$120M	-$105M	-14.4%
Net Income	-$104M	-$89M	-16.5%